FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data

The FDA on Friday approved Pfizer and Arvinas' drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will take it. The drug will be ...